High Cytotoxic and Specific Migratory Potencies of Senescent CD8+CD57+ Cells in HIV-Infected and Uninfected Individuals1

CD8+CD57+ T lymphocytes, present at low levels in the peripheral blood of healthy individuals expand during HIV infection and remain elevated during chronic infection. Their role in the immune response remains unclear. We performed a large-scale gene array analysis (3158 genes) to characterize them and, interestingly, found no distinction in the transcriptional profiles of CD8+CD57+ T lymphocytes from HIV-infected and uninfected subjects. In both groups, these cells showed specificity for multiple Ags and produced large amounts of IFN-γ and TNF-α. The transcriptional profiles of CD8+CD57+ and CD8+CD57− cells, however, differed substantially. We propose that CD8+CD57+ cells were Ag-driven effector cells with very high cytotoxic effector potential including perforin, granzymes, and granulysin, regardless of HIV status. At both the messenger and protein levels, they expressed more adhesion molecules and fewer chemokine receptors (CCR7 and CXCR4) than CD8+CD57− cells but expressed preferentially CX3CR1. The lower expression level of genes involved in cell cycle regulation showed limited proliferation capacities of CD8+CD57+ even in response to TCR and IL-2, IL-7, and IL-15 stimulation. CD8+CD57+ T cells from both HIV and uninfected subjects maintain effective cytotoxic potentials but are destined to migrate to nonlymphoid tissues without further cycling.

[1]  R. Detels,et al.  T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. , 1989, Clinical immunology and immunopathology.

[2]  A. Foussat,et al.  Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. , 2001, Blood.

[3]  F. Gao,et al.  Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Sandra A. Kinnear,et al.  Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System1 , 2000, The Journal of Immunology.

[5]  B. Autran,et al.  Alveolar CD8+CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions. , 1994, American journal of respiratory and critical care medicine.

[6]  T. Honjo,et al.  Fractalkine and macrophage‐derived chemokine: T cell‐attracting chemokines expressed in T cell area dendritic cells , 1999, European journal of immunology.

[7]  D. Joshua,et al.  T‐cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells , 2000, British journal of haematology.

[8]  P. Moss,et al.  Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. , 2002, The Journal of infectious diseases.

[9]  C. Hallahan,et al.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors , 2002, Nature Immunology.

[10]  J. Puck,et al.  Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome. , 1985, The Journal of infectious diseases.

[11]  N. Shinomiya,et al.  Analysis of the susceptibility of CD57+ T cells to CD3‐mediated apoptosis , 2005, Clinical and experimental immunology.

[12]  G. Janossy,et al.  Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. , 1981, Clinical and experimental immunology.

[13]  E. Kremmer,et al.  Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells , 1999, European journal of immunology.

[14]  P. Gregersen,et al.  A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. , 1990, Annals of internal medicine.

[15]  C. Balch,et al.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). , 1981, Journal of immunology.

[16]  P. Gregersen,et al.  A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell Repertoire , 1998, Molecular medicine.

[17]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Autran,et al.  A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. , 1991, Blood.

[19]  C. McNair,et al.  Expansion of the CD57 subset of CD8 T cells in HIV-1 infection is related to CMV serostatus. , 1999, AIDS.

[20]  A. Krensky,et al.  Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. , 1997, Journal of immunology.

[21]  T. Rème,et al.  Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. , 1993, Arthritis and rheumatism.

[22]  B. Autran,et al.  Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. , 1989, Journal of immunology.

[23]  S. Granjeaud,et al.  Multiplex messenger assay: simultaneous, quantitative measurement of expression of many genes in the context of T cell activation. , 1996, Nucleic acids research.

[24]  R. Koup,et al.  Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know , 2004, Nature Medicine.

[25]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[26]  C. Katlama,et al.  A lectin‐binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity , 1991, European journal of immunology.

[27]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[28]  N. Hogg,et al.  The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. , 1998, Journal of immunology.

[29]  R. Schooley,et al.  Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. , 1983, The New England journal of medicine.

[30]  N. Letvin,et al.  IL-15 stimulates the expansion of AIDS virus-specific CTL. , 1996, Journal of immunology.

[31]  N. Copeland,et al.  Mad3 and Mad4: novel Max‐interacting transcriptional repressors that suppress c‐myc dependent transformation and are expressed during neural and epidermal differentiation. , 1995, The EMBO journal.

[32]  T. Schall,et al.  Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up‐regulated upon dendritic cell maturation , 1999, European journal of immunology.

[33]  S. Rowland-Jones,et al.  Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.

[34]  G F Babcock,et al.  Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. , 1983, Journal of immunology.

[35]  Sudhir Gupta Abnormality of Leu 2+7+ cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals , 1986, Journal of Clinical Immunology.

[36]  B. Autran,et al.  The chemokine receptor CX3CR1 controls homing and anti‐viral potencies of CD8 effector‐memory T lymphocytes in HIV‐infected patients , 2003, AIDS.

[37]  O. Yoshie,et al.  Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 Expression , 2002, The Journal of Immunology.

[38]  F. Bertucci,et al.  Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. , 1999, Human molecular genetics.

[39]  D. Richman,et al.  Dynamics of T Cell Responses in HIV Infection , 2002, The Journal of Immunology.

[40]  G. Jansen,et al.  Enhanced expression of fractalkine in HIV-1 associated dementia , 2001, Journal of Neuroimmunology.

[41]  B. Autran,et al.  Human immunodeficiency virus-related lymphocytic alveolitis. , 1988, Chest.

[42]  S. Granjeaud,et al.  Differential gene expression in the murine thymus assayed by quantitative hybridization of arrayed cDNA clones. , 1995, Genomics.

[43]  V. Calvez,et al.  CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. , 1998, International immunology.

[44]  A. Basten,et al.  Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. , 2001, Blood.

[45]  J. Farcet,et al.  Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation. , 1986, Journal of immunology.

[46]  Nitin J. Karandikar,et al.  Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. , 2003, Blood.

[47]  J. Lisziewicz,et al.  Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection. , 1999, AIDS.

[48]  T. Schall,et al.  The isolation and sequence of a novel gene from a human functional T cell line , 1987, The Journal of experimental medicine.

[49]  P. Moss,et al.  Cytomegalovirus Seropositivity Drives the CD8 T Cell Repertoire Toward Greater Clonality in Healthy Elderly Individuals1 , 2002, The Journal of Immunology.

[50]  J. Phair,et al.  Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. , 1988, Journal of acquired immune deficiency syndromes.

[51]  J. Hauw,et al.  Extensive T8-positive lymphocytic visceral infiltration in a homosexual man. , 1987, The American journal of medicine.

[52]  K. Wood,et al.  Apoptosis of CD57+ and CD57- lymphocytes in the lung and blood of HIV-infected subjects. , 2005, Clinical immunology.

[53]  A. Krensky,et al.  Granulysin, a Cytolytic Molecule, Is Also a Chemoattractant and Proinflammatory Activator 1 , 2005, The Journal of Immunology.

[54]  L. Lanier,et al.  Comparative studies of human FcRIII-positive and negative natural killer cells. , 1989, Journal of immunology.

[55]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[56]  A. Gratwohl,et al.  The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. , 1985, Clinical and experimental immunology.

[57]  R. Koup,et al.  Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.

[58]  R. Detels,et al.  Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. , 1984, The American journal of medicine.